These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36910213)

  • 41. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
    Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and Outcomes of Faecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease.
    Nicholson MR; Alexander E; Ballal S; Davidovics Z; Docktor M; Dole M; Gisser JM; Goyal A; Hourigan SK; Jensen MK; Kaplan JL; Kellermayer R; Kelsen JR; Kennedy MA; Khanna S; Knackstedt ED; Lentine J; Lewis JD; Michail S; Mitchell PD; Oliva-Hemker M; Patton T; Queliza K; Sidhu S; Solomon AB; Suskind DL; Weatherly M; Werlin S; de Zoeten EF; Kahn SA;
    J Crohns Colitis; 2022 Jun; 16(5):768-777. PubMed ID: 34788420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection.
    Staley C; Kaiser T; Vaughn BP; Graiziger C; Hamilton MJ; Kabage AJ; Khoruts A; Sadowsky MJ
    mBio; 2019 Jul; 10(4):. PubMed ID: 31337728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Associates With Functional Alterations in Circulating microRNAs.
    Monaghan TM; Seekatz AM; Markham NO; Yau TO; Hatziapostolou M; Jilani T; Christodoulou N; Roach B; Birli E; Pomenya O; Louie T; Lacy DB; Kim P; Lee C; Kao D; Polytarchou C
    Gastroenterology; 2021 Jul; 161(1):255-270.e4. PubMed ID: 33844988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fecal microbiota transplantation for recurrent
    Sandhu A; Chopra T
    Therap Adv Gastroenterol; 2021; 14():17562848211053105. PubMed ID: 34992678
    [No Abstract]   [Full Text] [Related]  

  • 46. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection.
    Perler BK; Chen B; Phelps E; Allegretti JR; Fischer M; Ganapini V; Krajiceck E; Kumar V; Marcus J; Nativ L; Kelly CR
    J Clin Gastroenterol; 2020 Sep; 54(8):701-706. PubMed ID: 32011405
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation.
    He R; Li P; Wang J; Cui B; Zhang F; Zhao F
    Gut Microbes; 2022; 14(1):2100197. PubMed ID: 35854629
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation.
    Staley C; Kaiser T; Vaughn BP; Graiziger CT; Hamilton MJ; Rehman TU; Song K; Khoruts A; Sadowsky MJ
    Microbiome; 2018 Sep; 6(1):166. PubMed ID: 30227892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital.
    Barberio B; Facchin S; Mele E; D'Incà R; Sturniolo GC; Farinati F; Zingone F; Quagliariello A; Ghisa M; Massimi D; Casadei C; Savarino EV
    Therap Adv Gastroenterol; 2020; 13():1756284820934315. PubMed ID: 32774464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fecal microbiota transplantation for treatment of patients with recurrent
    Voth E; Khanna S
    Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection.
    Haifer C; Paramsothy S; Borody TJ; Clancy A; Leong RW; Kaakoush NO
    mSystems; 2021 Feb; 6(1):. PubMed ID: 33531405
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with
    Yoon H; Shim HI; Seol M; Shin CM; Park YS; Kim N; Lee DH
    Gut Liver; 2021 Jan; 15(1):61-69. PubMed ID: 32839363
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In Silico Analysis of Changes in Predicted Metabolic Capabilities of Intestinal Microbiota after Fecal Microbial Transplantation for Treatment of Recurrent
    Dahiya M; Jovel J; Monaghan T; Wong K; Elhenawy W; Chui L; McAlister F; Kao D
    Microorganisms; 2023 Apr; 11(4):. PubMed ID: 37110500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fecal microbiota transplantation in a toddler after heart transplant was a safe and effective treatment for recurrent Clostridiodes difficile infection: A case report.
    Spinner JA; Bocchini CE; Luna RA; Thapa S; Balderas MA; Denfield SW; Dreyer WJ; Nagy-Szakal D; Ihekweazu FD; Versalovic J; Savidge T; Kellermayer R
    Pediatr Transplant; 2020 Feb; 24(1):e13598. PubMed ID: 31617299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FMT: What's Next? A Narrative Review of Fecal Microbiota Transplantation in Clostridioides difficile Infection and Inflammatory Bowel Disease.
    Patwa SA; Ward C; Kelly CR
    R I Med J (2013); 2022 Nov; 105(9):20-24. PubMed ID: 36300959
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway.
    Monaghan T; Mullish BH; Patterson J; Wong GK; Marchesi JR; Xu H; Jilani T; Kao D
    Gut Microbes; 2019; 10(2):142-148. PubMed ID: 30183484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Small Intestinal Bacterial Overgrowth: Should Screening Be Included in the Pre-fecal Microbiota Transplantation Evaluation?
    Allegretti JR; Kassam Z; Chan WW
    Dig Dis Sci; 2018 Jan; 63(1):193-197. PubMed ID: 29188472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection.
    Allegretti JR; Kelly CR; Grinspan A; Mullish BH; Hurtado J; Carrellas M; Marcus J; Marchesi JR; McDonald JAK; Gerardin Y; Silverstein M; Pechlivanis A; Barker GF; Miguens Blanco J; Alexander JL; Gallagher KI; Pettee W; Phelps E; Nemes S; Sagi SV; Bohm M; Kassam Z; Fischer M
    Inflamm Bowel Dis; 2021 Aug; 27(9):1371-1378. PubMed ID: 33155639
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes of a Multidisciplinary Clinic in Evaluating Recurrent
    Shin JH; Chaplin AS; Hays RA; Kolling GL; Vance S; Guerrant RL; Archbald-Pannone L; Warren CA
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31315214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systematic review with meta-analysis: encapsulated faecal microbiota transplantation - evidence for clinical efficacy.
    Cold F; Baunwall SMD; Dahlerup JF; Petersen AM; Hvas CL; Hansen LH
    Therap Adv Gastroenterol; 2021; 14():17562848211041004. PubMed ID: 34484424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.